| Product ID | 51662-1481_9d4d66f7-fa15-e832-e053-2a95a90a8b62 |
| NDC | 51662-1481 |
| Product Type | Human Prescription Drug |
| Proprietary Name | NEXTERONE (AMIODARONE HCI) |
| Generic Name | Nexterone (amiodarone Hci) |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2020-01-29 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022325 |
| Labeler Name | HF Acquisition Co LLC, DBA HealthFirst |
| Substance Name | AMIODARONE HYDROCHLORIDE |
| Active Ingredient Strength | 2 mg/mL |
| Pharm Classes | Cytochrome P450 2C9 Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Antiarrhythmic [EPC],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 1A2 Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |